Selected research
Industry Research
Carmustine Industry Research Report 2026
Market perspective
The global Carmustine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Carmustine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Carmustine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Carmustine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Carmustine include Eisai, Tianjin Kingyork, Zydus Pharmaceuticals, Bristol-Myers Squibb, STI Pharma, Sanli Ilac, Pharmaplan, Obvius Pharmaceuticals and Navinta, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Carmustine market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Carmustine Market by Company
Eisai
Tianjin Kingyork
Zydus Pharmaceuticals
Bristol-Myers Squibb
STI Pharma
Sanli Ilac
Pharmaplan
Obvius Pharmaceuticals
Navinta
MGI Pharma
Marcan Pharmaceuticals
Emcure Pharms
Arbor Pharms
Amneal Pharms
Carmustine Segment by Type
100mg Injection
125mg Injection
Carmustine Segment by Application
Medulloblastoma and Astrocytoma
Multiple Myeloma
Glioblastoma Multiforme
Lymphoma
Glioma
Others
Carmustine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Carmustine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Carmustine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Carmustine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Carmustine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Carmustine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Carmustine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 100mg Injection
- 125mg Injection
Applications
- Medulloblastoma and Astrocytoma
- Multiple Myeloma
- Glioblastoma Multiforme
- Lymphoma
- Glioma
- Others
Companies covered
- Eisai
- Tianjin Kingyork
- Zydus Pharmaceuticals
- Bristol-Myers Squibb
- STI Pharma
- Sanli Ilac
- Pharmaplan
- Obvius Pharmaceuticals
- Navinta
- MGI Pharma
- Marcan Pharmaceuticals
- Emcure Pharms
- Arbor Pharms
- Amneal Pharms
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Carmustine Market Size (2021-2032)
- 2.2.2 Global Carmustine Sales (2021-2032)
- 2.2.3 Global Carmustine Market Average Price (2021-2032)
- 2.3 Carmustine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 100mg Injection
- 2.3.3 125mg Injection
- 2.4 Carmustine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Medulloblastoma and Astrocytoma
- 2.4.3 Multiple Myeloma
- 2.4.4 Glioblastoma Multiforme
- 2.4.5 Lymphoma
- 2.4.6 Glioma
- 2.4.7 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Carmustine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Carmustine Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Carmustine Revenue of Manufacturers (2021-2026)
- 3.4 Global Carmustine Average Price by Manufacturers (2021-2026)
- 3.5 Global Carmustine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Carmustine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Carmustine, Product Type & Application
- 3.8 Global Manufacturers of Carmustine, Established Date
- 3.9 Global Carmustine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Eisai
- 4.1.1 Eisai Company Information
- 4.1.2 Eisai Business Overview
- 4.1.3 Eisai Carmustine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Eisai Carmustine Product Portfolio
- 4.1.5 Eisai Recent Developments
- 4.2 Tianjin Kingyork
- 4.2.1 Tianjin Kingyork Company Information
- 4.2.2 Tianjin Kingyork Business Overview
- 4.2.3 Tianjin Kingyork Carmustine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Tianjin Kingyork Carmustine Product Portfolio
- 4.2.5 Tianjin Kingyork Recent Developments
- 4.3 Zydus Pharmaceuticals
- 4.3.1 Zydus Pharmaceuticals Company Information
- 4.3.2 Zydus Pharmaceuticals Business Overview
- 4.3.3 Zydus Pharmaceuticals Carmustine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Zydus Pharmaceuticals Carmustine Product Portfolio
- 4.3.5 Zydus Pharmaceuticals Recent Developments
- 4.4 Bristol-Myers Squibb
- 4.4.1 Bristol-Myers Squibb Company Information
- 4.4.2 Bristol-Myers Squibb Business Overview
- 4.4.3 Bristol-Myers Squibb Carmustine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Bristol-Myers Squibb Carmustine Product Portfolio
- 4.4.5 Bristol-Myers Squibb Recent Developments
- 4.5 STI Pharma
- 4.5.1 STI Pharma Company Information
- 4.5.2 STI Pharma Business Overview
- 4.5.3 STI Pharma Carmustine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 STI Pharma Carmustine Product Portfolio
- 4.5.5 STI Pharma Recent Developments
- 4.6 Sanli Ilac
- 4.6.1 Sanli Ilac Company Information
- 4.6.2 Sanli Ilac Business Overview
- 4.6.3 Sanli Ilac Carmustine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sanli Ilac Carmustine Product Portfolio
- 4.6.5 Sanli Ilac Recent Developments
- 4.7 Pharmaplan
- 4.7.1 Pharmaplan Company Information
- 4.7.2 Pharmaplan Business Overview
- 4.7.3 Pharmaplan Carmustine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Pharmaplan Carmustine Product Portfolio
- 4.7.5 Pharmaplan Recent Developments
- 4.8 Obvius Pharmaceuticals
- 4.8.1 Obvius Pharmaceuticals Company Information
- 4.8.2 Obvius Pharmaceuticals Business Overview
- 4.8.3 Obvius Pharmaceuticals Carmustine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Obvius Pharmaceuticals Carmustine Product Portfolio
- 4.8.5 Obvius Pharmaceuticals Recent Developments
- 4.9 Navinta
- 4.9.1 Navinta Company Information
- 4.9.2 Navinta Business Overview
- 4.9.3 Navinta Carmustine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Navinta Carmustine Product Portfolio
- 4.9.5 Navinta Recent Developments
- 4.10 MGI Pharma
- 4.10.1 MGI Pharma Company Information
- 4.10.2 MGI Pharma Business Overview
- 4.10.3 MGI Pharma Carmustine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 MGI Pharma Carmustine Product Portfolio
- 4.10.5 MGI Pharma Recent Developments
- 4.11 Marcan Pharmaceuticals
- 4.11.1 Marcan Pharmaceuticals Company Information
- 4.11.2 Marcan Pharmaceuticals Business Overview
- 4.11.3 Marcan Pharmaceuticals Carmustine Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Marcan Pharmaceuticals Carmustine Product Portfolio
- 4.11.5 Marcan Pharmaceuticals Recent Developments
- 4.12 Emcure Pharms
- 4.12.1 Emcure Pharms Company Information
- 4.12.2 Emcure Pharms Business Overview
- 4.12.3 Emcure Pharms Carmustine Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Emcure Pharms Carmustine Product Portfolio
- 4.12.5 Emcure Pharms Recent Developments
- 4.13 Arbor Pharms
- 4.13.1 Arbor Pharms Company Information
- 4.13.2 Arbor Pharms Business Overview
- 4.13.3 Arbor Pharms Carmustine Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Arbor Pharms Carmustine Product Portfolio
- 4.13.5 Arbor Pharms Recent Developments
- 4.14 Amneal Pharms
- 4.14.1 Amneal Pharms Company Information
- 4.14.2 Amneal Pharms Business Overview
- 4.14.3 Amneal Pharms Carmustine Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Amneal Pharms Carmustine Product Portfolio
- 4.14.5 Amneal Pharms Recent Developments
5 Global Carmustine Market Scenario by Region
- 5.1 Global Carmustine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Carmustine Sales by Region: 2021-2032
- 5.2.1 Global Carmustine Sales by Region: 2021-2026
- 5.2.2 Global Carmustine Sales by Region: 2027-2032
- 5.3 Global Carmustine Revenue by Region: 2021-2032
- 5.3.1 Global Carmustine Revenue by Region: 2021-2026
- 5.3.2 Global Carmustine Revenue by Region: 2027-2032
- 5.4 North America Carmustine Market Facts & Figures by Country
- 5.4.1 North America Carmustine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Carmustine Sales by Country (2021-2032)
- 5.4.3 North America Carmustine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Carmustine Market Facts & Figures by Country
- 5.5.1 Europe Carmustine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Carmustine Sales by Country (2021-2032)
- 5.5.3 Europe Carmustine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Carmustine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Carmustine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Carmustine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Carmustine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Carmustine Market Facts & Figures by Country
- 5.7.1 South America Carmustine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Carmustine Sales by Country (2021-2032)
- 5.7.3 South America Carmustine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Carmustine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Carmustine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Carmustine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Carmustine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Carmustine Sales by Type (2021-2032)
- 6.1.1 Global Carmustine Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Carmustine Sales Market Share by Type (2021-2032)
- 6.2 Global Carmustine Revenue by Type (2021-2032)
- 6.2.1 Global Carmustine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Carmustine Revenue Market Share by Type (2021-2032)
- 6.3 Global Carmustine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Carmustine Sales by Application (2021-2032)
- 7.1.1 Global Carmustine Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Carmustine Sales Market Share by Application (2021-2032)
- 7.2 Global Carmustine Revenue by Application (2021-2032)
- 7.2.1 Global Carmustine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Carmustine Revenue Market Share by Application (2021-2032)
- 7.3 Global Carmustine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Carmustine Value Chain Analysis
- 8.1.1 Carmustine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Carmustine Production Mode & Process
- 8.2 Carmustine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Carmustine Distributors
- 8.2.3 Carmustine Customers
9 Global Carmustine Analyzing Market Dynamics
- 9.1 Carmustine Industry Trends
- 9.2 Carmustine Industry Drivers
- 9.3 Carmustine Industry Opportunities and Challenges
- 9.4 Carmustine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst